Abnova’s Sustainability Journey and EcoVadis Fast Mover Award 

 

  Badge-FastMover-EcoVadis.png (27 KB)

Neihu, Taiwan (Mar 13, 2024)  

 

At Abnova, we prioritize sustainability by collaborating with EcoVadis to assess and enhance our performance in this field. EcoVadis' methodology covers environment, labor and human rights, ethics, and sustainable procurement, closely linked with the Sustainable Development Goals (SDGs).

 

In today's ESG-focused environment, our commitment to sustainability has become increasingly significant. We deeply understand the profound impact of our actions on the future, driving our relentless pursuit of progress. Sustainability is seamlessly integrated into various aspects of our business operations, from product quality to workplace environments and ethical standards. Actively striving to minimize waste, conserve resources, and reduce our environmental footprint is fundamental to our approach.

 

Our journey toward sustainability is one of continuous evolution. We are dedicated to fostering a culture of innovation and responsibility, exceeding stakeholder expectations through collaborative efforts, transparency, and accountability. This year, Abnova proudly received the EcoVadis Fast Mover Award, affirming the effectiveness of our persistent efforts and inspiring us to continue advancing. We will persist in collaborating with stakeholders, cultivating a culture of innovation and responsibility, and maintaining transparency and accountability. This unwavering commitment reinforces our mission, guiding us toward a more sustainable future.

Abnova

+886-2-87511888

sales@abnova.com

Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)